Addressing the challenge of post-approval regulation of pharmaceuticals
The case for independent third-party evaluations
Bibliographic Data
| ID | 21467896 |
|---|---|
| Authors | Itai Bavli (0000-0002-7323-0435, Bar-Ilan University, corresponding author), Yair Sadaka (0000-0002-4022-4020, Israel Ministry of Health), Chen Yanover (0000-0003-3663-4286, IMI TAMI Institute for Research and Development), Joel Lexchin (0000-0001-5120-8029, York University) |
| Year | 2026 |
| Volume | 167 |
| Pages | 105585 |
| Publication date | 2026-05-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Health Policy (JOURNAL) |
| Journal identifiers | ISSN: 0168-8510 • E-ISSN: 1872-6054 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.healthpol.2026.105585 |
| PMID | 41724137 |
| OpenAlex | W7129434159 |
| Language | EN |
| References cited | 21 |
MEDLINE · Intellectual Property and Patents · Pharmaceutical Economics and Policy · Regulation and Compliance Studies · Health Policy
| Highly cited | No |
|---|